Created in 2011 (United Kingdom), CANCERPATH own 6 sister brands and 2617 competing brands. The CANCERPATH brand is owned by Novacyt, a company listed in Etats-Unis. Its International Securities Identification Number (ISIN) is FR0010397232. CANCERPATH belongs to the Medical Diagnostics & Research business sector.
Share price and profitability of the share Novacyt (CANCERPATH)
Buy Novacyt share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.
Stock market history Novacyt (CANCERPATH)
*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances
past performances do not prejudice future performances
